PMID- 36442291 OWN - NLM STAT- MEDLINE DCOM- 20230206 LR - 20230218 IS - 1873-3360 (Electronic) IS - 0306-4530 (Linking) VI - 148 DP - 2023 Feb TI - Prediction of cord blood leptin on infant's neurodevelopment: A birth cohort in rural Yunnan, China. PG - 105955 LID - S0306-4530(22)00296-7 [pii] LID - 10.1016/j.psyneuen.2022.105955 [doi] AB - BACKGROUND: Leptin, one of the peptide hormones secreted by adipocytes, plays a vital part in metabolism, but its role in early-life neurodevelopment remains poorly understood. METHODS: We performed leptin analysis on 323 cord blood samples collected from a birth cohort in Yunnan rural area, China, and assessed infants' neurodevelopment at one year of age by the Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III). Multiple linear regression and binary logistic regression models were used to explore the associations between cord blood leptin (CBL) concentrations and infants' neurodevelopment and the ability of CBL to predict the probabilities of infants' neurodevelopment delay. RESULTS: Overall, 323 infants were included in this study. The median concentration of CBL was 4.7 ng/ml. The proportion of 1-year-old infants identified as being neurodevelopmental delayed was 34.5%, and delays in cognitive, language, and motor domains were 11.1%, 26.6%, and 13.9%, respectively. Multiple linear regression analyses manifested that the CBL concentration (log10-transformed) was positively correlated with the cognitive, language, and motor composite scores in infants, respectively (beta = 7.76, 95%CI: 3.81-11.71; beta = 6.73, 95%CI: 3.41-10.06; and beta = 6.88, 95%CI: 3.48-10.29, respectively). Binary logistic regression analysis showed that compared with the higher, lower CBL (< 4.7 ng/ml) yielded a 1.41-fold increase in the risk of language development delay (OR = 2.41,95%CI: 1.42-4.09), a 1.49-fold higher risk of motor development delay (OR = 2.49, 95%CI: 1.25-4.96), and a 1.71-fold higher risk of neurodevelopment delay (OR = 2.71, 95%CI: 1.64-4.48) among infants. The prediction models showed that the probabilities of development delay in infants' language, motor, and neurodevelopment increased with the decline of CBL concentrations [r(s) = -0.63 (95% CI: -0.71, -0.56), r(s) = -0.46 (95% CI: -0.55, -0.38), r(s) = -0.55 (95% CI: -0.63, -0.46), respectively]. CONCLUSION: The decline of CBL was associated with the decrease in infants' neurodevelopment scores at one year of age. CBL below 4.7 ng/ml may increase the risk of infants' neurodevelopment delay. The probabilities of infants' neurodevelopment delay increased with the decrease of CBL concentrations. CBL may be a predictor of the probability of children's neurodevelopment delay. CI - Copyright (c) 2022. Published by Elsevier Ltd. FAU - Chen, Shuqi AU - Chen S AD - School of Public Health, Kunming Medical University, Kunming, China; Ministry of Child Health, Longgang District Maternity & Child Healthcare Hospital of Shenzhen, Shenzhen, Guangdong, China. FAU - Xiao, Xia AU - Xiao X AD - School of Public Health, Kunming Medical University, Kunming, China. FAU - Song, Xiaoxiao AU - Song X AD - School of Public Health, Kunming Medical University, Kunming, China. FAU - Qi, Zhiye AU - Qi Z AD - School of Public Health, Kunming Medical University, Kunming, China; Department of Pediatrics, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. FAU - Li, Yan AU - Li Y AD - School of Public Health, Kunming Medical University, Kunming, China. Electronic address: yanli20021965@21cn.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221019 PL - England TA - Psychoneuroendocrinology JT - Psychoneuroendocrinology JID - 7612148 RN - 0 (Leptin) SB - IM MH - Humans MH - Infant MH - *Birth Cohort MH - *Leptin MH - Fetal Blood MH - Child Development MH - China OTO - NOTNLM OT - Cord blood leptin OT - Infant OT - Neurodevelopment delay COIS- Conflict of interest The authors have no conflict of interest to declare. EDAT- 2022/11/29 06:00 MHDA- 2023/02/07 06:00 CRDT- 2022/11/28 18:15 PHST- 2022/06/17 00:00 [received] PHST- 2022/09/17 00:00 [revised] PHST- 2022/10/17 00:00 [accepted] PHST- 2022/11/29 06:00 [pubmed] PHST- 2023/02/07 06:00 [medline] PHST- 2022/11/28 18:15 [entrez] AID - S0306-4530(22)00296-7 [pii] AID - 10.1016/j.psyneuen.2022.105955 [doi] PST - ppublish SO - Psychoneuroendocrinology. 2023 Feb;148:105955. doi: 10.1016/j.psyneuen.2022.105955. Epub 2022 Oct 19.